ArticleCureus2026
The Role of Bedside Medication Delivery in Reducing Hospital Readmissions: A Quality Improvement Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transitions of care place patients at elevated risk for adverse events that may result in hospital readmission, including medication non-adherence after discharge. We sought to apply principles of quality improvement to improve medication adherence after hospitalization by implementing a pharmacist-led bedside medication delivery program at the time of hospital discharge. Our program was not associated with reduced 30-day hospital readmissions in the one-year period analyzed. We further stratified patients by demographic characteristics, insurance status, and zip code to better identify those at elevated risk of readmission or ineligible for enrollment in the program. After comparing our results with similar programs reported in the literature, we postulate that isolated bedside medication-delivery programs, as presently implemented, do not meaningfully reduce hospital readmissions in most cases. There is some evidence that these programs may benefit from being bundled with multi-faceted interventions in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.